Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

7.54
Delayed Data
As of 12:56pm ET
 -0.01 / -0.13%
Today’s Change
6.68
Today|||52-Week Range
22.93
-54.41%
Year-to-Date
No recent news for Uniqure NV.

Today’s Trading

Previous close7.55
Today’s open7.55
Day’s range7.27 - 7.71
Volume133,942
Average volume (3 months)295,978
Market cap$187.4M
Dividend yield--
Data as of 12:56pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-25.40%
Earnings growth (this year)-0.97%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+68.18%
P/E ratio--
Price/Sales34.95
Price/Book1.41

Competitors

 Today’s
change
Today’s
% change
PIPPharmAthene Inc+0.03+1.06%
ASTAsterias Biotherapeu...-0.05-1.19%
KMDAKamada Ltd+0.09+1.79%
CBMGCellular Biomedicine...-0.11-0.79%
Data as of 1:11pm ET, 09/30/2016

Financials

Next reporting dateNovember 28, 2016
EPS forecast (this quarter)-$0.88
Annual revenue (last year)$10.5M
Annual profit (last year)-$79.3M
Net profit margin-758.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Matt Kapusta
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts

Search for Jobs